Medtronic Cancer Pain Study Underscores Focus On Infusion Pump Systems
This article was originally published in The Gray Sheet
Medtronic is looking to combination products incorporating infusion pump systems as another growth vehicle for the firm's top line going into the 2003 fiscal year that began May 1
You may also be interested in...
Medtronic's SynchroMed implantable drug pump poses medication error risk due to an inaccurate listing of intrathecal drugs, an Oct. 31 device alert by the UK's Medical Devices Agency indicates
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.